Perfusion of99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target

This publication has 29 references indexed in Scilit:

• Strategies for vascular targeting in tumors
  International Journal of Cancer, 2002
• CD105 Antibody for Targeting of Tumor Vascular Endothelial Cells
  Published by Springer Nature ,2002
• Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters
  Gene Therapy, 2001
• Genes Expressed in Human Tumor Endothelium
  Science, 2000
• An Address System in the Vasculature of Normal Tissues and Tumors
  Annual Review of Immunology, 2000
• Clinical applications of angiogenic growth factors and their inhibitors
  Nature Medicine, 1999
• Fighting Cancer by Attacking its Blood Supply
  Scientific American, 1996
• EDITORIAL. CD105 AND ANGIOGENESIS
  The Journal of Pathology, 1996
• Role of angiogenesis in patients with cerebral ischemic stroke.
  Stroke, 1994
• Vascular attack as a therapeutic strategy for cancer
  Cancer and Metastasis Reviews, 1990